Parks Michael J, Marshall Daniela, Kimmel Heather L, Kingsbury John H, Everard Colm D, Aboaziza Eiman, Blanco Carlos, Compton Wilson M
National Institute on Drug Abuse, National Institutes of Health, Bethesda, Maryland.
Kelly Government Solutions, Rockville, Maryland.
JAMA Netw Open. 2025 Feb 3;8(2):e2460471. doi: 10.1001/jamanetworkopen.2024.60471.
Research on cumulative disabilities and tobacco use in the current tobacco landscape is lacking.
To examine prevalence of tobacco use across cumulative disabilities within and across years among US adults.
DESIGN, SETTING, AND PARTICIPANTS: Representative cross-sectional surveys of the US adult (aged ≥18 years) civilian, noninstitutionalized population from the Population Assessment of Tobacco and Health (PATH) Study were compared across 2013 to 2014 (wave 1), 2016 to 2018 (wave 4), and 2022 to 2023 (wave 7). Age-adjusted estimates and change scores were compared using design-based significance tests. Data were analyzed from November 2023 and April 2024.
Past 30-day use of tobacco (cigarette, electronic nicotine [e-product], traditional cigar, filtered cigar, cigarillo, pipe, hookah, and smokeless products); disability types (mobility, self-care, independent living, cognitive, hearing, and vision) summed to generate a 4-level cumulative disability measure (0, 1, 2, or ≥3).
In 2013 to 2014, among 32 314 participants at wave 1, 3110 participants were 65 years or older (18.2%), 15 993 (51.9%) were female, 5536 (15.2%) were Hispanic, 4496 (11.2%) were non-Hispanic Black, 19 295 (66.0%) were non-Hispanic White, and 2428 (7.5%) were another non-Hispanic race. A total of 32 314 adults were included in 2013 to 2014, 33 638 in 2016 to 2018, and 30 681 in 2022 to 2023. In 2013 to 2014, any tobacco use prevalence for those with no disabilities was 25.4% (95% CI, 24.7% to 26.1%), while prevalence was 40.2% (95% CI, 38.6% to 41.8%), 48.9% (95% CI, 45.4% to 52.5%), and 51.8% (95% CI, 48.6% to 55.0%) for those with 1, 2, and 3 or more disabilities, respectively. Any tobacco, cigarette, e-product, cigarillo, filtered cigar, and pipe use were consistently higher among those with multiple disabilities compared with those with 0 or 1 disability. Prevalence was highest among those with 3 or more disabilities for all products. Tobacco use declined over time, except e-product use increased. However, not all declines in prevalence between 2013 to 2014 and 2022 to 2023 were significant among those with 3 or more disabilities. The declines for those who used any tobacco (-4.6%; 95% CI, -8.7% to -0.6%) and cigarettes (-8.9%; 95% CI, -12.7% to -5.1%) were small, and increases in e-product use were large (4.6%; 95% CI, 1.0% to 8.3%) for those with 3 or more disabilities compared with other groups.
In this survey study, disparities in tobacco use existed across cumulative disabilities. Despite declines in tobacco use over time, differences in use across cumulative disabilities persisted or worsened, especially among those with 3 or more disabilities. Targeted prevention, screening, and cessation efforts inclusive of multiple products are needed.
在当前烟草环境下,关于累积残疾与烟草使用的研究尚属空白。
研究美国成年人中,历年及不同累积残疾程度人群的烟草使用流行情况。
设计、研究地点和参与者:对美国成年(≥18岁)平民非机构化人群进行具有代表性的横断面调查,数据来自烟草与健康人口评估(PATH)研究,时间跨度为2013年至2014年(第1波)、2016年至2018年(第4波)和2022年至2023年(第7波)。采用基于设计的显著性检验比较年龄调整后的估计值和变化分数。数据分析于2023年11月至2024年4月进行。
过去30天内使用烟草的情况(香烟、电子尼古丁产品[e产品]、传统雪茄、过滤嘴雪茄、小雪茄、烟斗、水烟和无烟产品);残疾类型(行动能力、自我护理、独立生活、认知、听力和视力)汇总后生成一个4级累积残疾指标(0、1、2或≥3)。
在2013年至2014年第1波的32314名参与者中,3110名参与者年龄在65岁及以上(18.2%),15993名(51.9%)为女性,5536名(15.2%)为西班牙裔,4496名(11.2%)为非西班牙裔黑人,19295名(66.0%)为非西班牙裔白人,2428名(7.5%)为其他非西班牙裔种族。2013年至2014年共纳入32314名成年人,2016年至2018年为33638名,2022年至2023年为30681名。2013年至2014年,无残疾者的任何烟草使用流行率为25.4%(95%CI,24.7%至26.1%),而有1、2和3种及以上残疾者的流行率分别为40.2%(95%CI,38.6%至41.8%)、48.9%(95%CI,45.4%至52.5%)和51.8%(95%CI,48.6%至55.0%)。与无残疾或有1种残疾者相比,有多种残疾者的任何烟草、香烟、e产品、小雪茄、过滤嘴雪茄和烟斗的使用一直更高。所有产品的使用流行率在有3种及以上残疾者中最高。除e产品使用增加外,烟草使用随时间下降。然而,在2013年至2014年和2022年至2023年期间,并非所有有3种及以上残疾者的流行率下降都具有显著性。与其他组相比,有3种及以上残疾者使用任何烟草(-4.6%;95%CI,-8.7%至-0.6%)和香烟(-8.9%;95%CI,-12.7%至-5.1%)的下降幅度较小,而e产品使用的增加幅度较大(4.6%;95%CI,1.0%至8.3%)。
在这项调查研究中,不同累积残疾程度人群的烟草使用存在差异。尽管烟草使用随时间下降,但不同累积残疾程度人群的使用差异持续存在或有所恶化,尤其是在有3种及以上残疾者中。需要开展针对多种产品的有针对性的预防、筛查和戒烟工作。